Michael Barbella, Managing Editor04.04.22
IQVIA has welcomed its fourth woman and 11th director to its board.
Sheila A. Stamps brings more than four decades of strategic, governance and operational management experience to her board role. During her career she held senior executive leadership positions in both public and private sector organizations, most recently as a senior investment advisor to the Comptroller of the State of New York for the NYS Common Retirement Fund and as Commissioner on the board of the New York State Insurance Fund, the state’s largest provider of worker’s compensation insurance. Prior to this, she was a managing director at Bank of America and managing director and Executive Management Committee member at Bank One London (now, JPMorgan Chase).
Stamps currently serves on the boards of three public companies, including Pitney Bowes Inc, a provider of global shipping and mailing solutions, where she has been a member of the Audit and Compensation committees since 2020; Atlas Air Worldwide Holdings Inc., a global provider of aircraft and aviation services, since 2018 where she serves as chair of the Audit and Finance committee; and MFA Financial Inc, a residential mortgage REIT, where she is a member of the Compensation and Nominating & Governance committees. She previously served on the board of CIT Group Inc., a publicly traded financial holding company, as a member of the Audit and Nominating & Governance committees from 2014 until its recent merger with First Citizens BancShares Inc. in January 2022.
“We are very pleased to welcome Sheila to our board of directors,” said Ari Bousbib, chairman and CEO of IQVIA. “Her mix of global experience within the public and private sectors and extensive corporate governance experience from her service on public boards across a diverse set of industries will strengthen our board and provide unique benefit to IQVIA.”
Stamps earned a bachelor of science degree in management sciences from Duke University and an MBA in finance from the University of Chicago. She also completed a Fellowship at Harvard University’s Weatherhead Center for International Affairs. In 2021, she was recognized as a “Most Influential Black Corporate Director” by Savoy Magazine and among the “2019 Most Influential Corporate Directors” by WomenInc. Magazine.
Ten of IQVIA's board members are independent directors.
IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. With approximately 77,000 employees, IQVIA conducts operations in more than 100 countries. The company uses a variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures.
Sheila A. Stamps brings more than four decades of strategic, governance and operational management experience to her board role. During her career she held senior executive leadership positions in both public and private sector organizations, most recently as a senior investment advisor to the Comptroller of the State of New York for the NYS Common Retirement Fund and as Commissioner on the board of the New York State Insurance Fund, the state’s largest provider of worker’s compensation insurance. Prior to this, she was a managing director at Bank of America and managing director and Executive Management Committee member at Bank One London (now, JPMorgan Chase).
Stamps currently serves on the boards of three public companies, including Pitney Bowes Inc, a provider of global shipping and mailing solutions, where she has been a member of the Audit and Compensation committees since 2020; Atlas Air Worldwide Holdings Inc., a global provider of aircraft and aviation services, since 2018 where she serves as chair of the Audit and Finance committee; and MFA Financial Inc, a residential mortgage REIT, where she is a member of the Compensation and Nominating & Governance committees. She previously served on the board of CIT Group Inc., a publicly traded financial holding company, as a member of the Audit and Nominating & Governance committees from 2014 until its recent merger with First Citizens BancShares Inc. in January 2022.
“We are very pleased to welcome Sheila to our board of directors,” said Ari Bousbib, chairman and CEO of IQVIA. “Her mix of global experience within the public and private sectors and extensive corporate governance experience from her service on public boards across a diverse set of industries will strengthen our board and provide unique benefit to IQVIA.”
Stamps earned a bachelor of science degree in management sciences from Duke University and an MBA in finance from the University of Chicago. She also completed a Fellowship at Harvard University’s Weatherhead Center for International Affairs. In 2021, she was recognized as a “Most Influential Black Corporate Director” by Savoy Magazine and among the “2019 Most Influential Corporate Directors” by WomenInc. Magazine.
Ten of IQVIA's board members are independent directors.
IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. With approximately 77,000 employees, IQVIA conducts operations in more than 100 countries. The company uses a variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures.